Creative Biolabs-Lipid Based Drug Delivery

Phosphatidic acid (PA)

Creative Biolabs is a biopharmaceutical company that holds a leadership position in the global market and focuses on improving human health through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate drug discovery.

Background of Phosphatidic Acid

The phosphatidic acid (PA) is an anionic lipid consisting of a negatively charged phosphomonoester headgroup attached to a hydrophobic diacylglycerol backbone. It is the simplest glycerophospholipid naturally occurring in all living organisms, and even though its content is minor in comparison to other cellular lipids, it is attracting more and more attention due to its various biological functions. PA is a key intermediate in the synthesis of neutral lipids (di- and triacylglycerol) and all glycerophospholipids. These include phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylinositol (PI), and the phosphatidylinositol phosphates (PIPs), which together make up the bulk of cellular membranes. In addition, PA is emerging as an important signaling lipid, which is thought to act by binding effector proteins and recruiting them to the membrane, thereby regulating the activity of proteins in cellular pathways.

Structure of Phosphatidic acid

PA is unique among phospholipids because it contains a phosphomonoester headgroup rather than the phosphodiesters in other phospholipids such as PS, where the phosphate group is also attached to the serine. The chemical structure of PA consists of alcohol, glycerol, in which two fatty acids (also known as acyl chains) and phosphate esters are esterified at the 1, 2 and 3 positions, respectively. The headgroup of PA is attached as a phosphomonoester (see Figure 1) and therefore has the potential to carry two negative charges, as opposed to a single negative charge on the more common anionic phospholipids such as PS and PI phosphate, which separate PA from all other diacyl-glycerophospholipids. Therefore, the specificity of the PA-protein interaction may be related to the ionization properties of the phosphomonoester headgroup. A number of PA binding proteins with various functions and cellular localization have been identified to date in yeast, plant and mammalian cells.

Fig.1 Structure and different models for signaling activity of PA. (Creative Biolabs Original)Fig.1 Structure and different models for signaling activity of PA.

The Application of Phosphatidic acid in Drug Delivery

Features of Our Services

  • Custom platform
  • Seasoned technology
  • One-stop pipeline
  • High efficiency

Creative Biolabs offers best-in-class technology to help researchers around the world solve a variety of difficult problems in the biomedical field. As a global company, our team of expert scientists also offers a wide range of custom services to every customer from around the world, covering every process of drug discovery. If you have this need, please feel free to contact us.

For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry